drugset / Trial / NCT01294384

Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease

NCT01294384

Phase 3 Completed 305 enrolled Allergan
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will investigate the safety, efficacy and acceptability of two new eye drop formulations compared with Refresh Tears® in patients with dry eye disease.

Timeline

Start
2011-05-01
Primary completion
2012-09-25
Completion
2012-09-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carboxymethylcellulose Other / unclassified Topical

Indications